Read-Across as an Alternative Approach for Assuring the Safety of Excipients

October 30, 2024 - 9:00am to 11:00am DST

Featuring:
> George Daston – Victor Mills Society Research Fellow, Procter & Gamble
> Ron Filler – President & CEO, Drug Development Consultants, Inc.
> Jeffrey Pitt - Lead Toxicologist, IFF
> Teresa Wegesser - Scientific Associate Director, Amgen

 
Read-across is the only accepted alternative to animal testing at present. Cheminformatic approaches to choose and assess the suitability of analogs for read-across have been developed, and high-content biotechnology methods such as global gene expression analysis have been used to prove biological similarity of analogs.